Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 EUR | +3.87% | +0.84% | -12.18% |
04-19 | ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. | AN |
04-18 | Intred appoints new board of directors; Daniele Peli chairman and Ad | AN |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Integrated Telecommunications Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.18% | 159M | - | ||
+7.48% | 196B | B+ | ||
+3.16% | 164B | C | ||
+0.18% | 116B | A- | ||
-1.10% | 93.7B | B- | ||
+13.64% | 71.82B | B- | ||
+4.51% | 59.9B | B | ||
-7.67% | 49.58B | B | ||
-18.02% | 38.31B | B | ||
-31.58% | 38.3B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ITD Stock
- Ratings Intred S.p.A.